Evidence map›Paper›PMID 42761209›Full record

ArticleCase reports in urology2026

Phosphodiesterase-5 Inhibitor Use Masking a Necrotizing Syphilitic Infection: A Rare Differential Diagnosis of Priapism.

Dimitrios M Papadimopoulos, Apostolos Chasapis, Konstantinos Sitaridis, Evangelos Arapis, Nikolaos Kalogeras, Apostolos Papalakis

Abstract read
In one paragraph

Article in Case reports in urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Dimitrios M PapadimopoulosDepartment of Urology, General Hospital of Thessaloniki "O Agios Dimitrios", Thessaloniki, Greece.ORCID https://orcid.org/0009-0004-1273-296X
Apostolos ChasapisDepartment of Urology, General Hospital of Thessaloniki "O Agios Dimitrios", Thessaloniki, Greece.ORCID https://orcid.org/0009-0003-8754-996X
Konstantinos SitaridisDepartment of Urology, General Hospital of Thessaloniki "O Agios Dimitrios", Thessaloniki, Greece.
Evangelos ArapisDepartment of Urology, General Hospital of Thessaloniki "O Agios Dimitrios", Thessaloniki, Greece.
Nikolaos KalogerasDepartment of Urology, General Hospital of Thessaloniki "O Agios Dimitrios", Thessaloniki, Greece.
Apostolos PapalakisDepartment of Urology, General Hospital of Thessaloniki "O Agios Dimitrios", Thessaloniki, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Acute penile enlargement is often presumed to indicate priapism, particularly after Phosphodiesterase-5 inhibitor use. However, alternative diagnoses, including infectious and necrotizing processes, should be considered-especially in patients with a history of unprotected sex-to avoid delayed or inappropriate management. Case Presentation: A 43-year-old male with a history of intravenous drug use presented with acute penile swelling and leukocytosis (20,500/ Conclusion: Acute penile enlargement following Phosphodiesterase-5 inhibitor use is not necessarily attributable to priapism and may instead be caused by infectious or necrotizing etiologies. Prompt recognition, initiation of antimicrobial therapy, and timely surgical intervention are critical to preserve penile tissue and erectile function.

Identifiers

PMID42761209
PMCPMC13586552

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.